Test Labs Successfully Completed MHRA GLP Inspection

Successful Completion of MHRA Good Laboratory Practice (GLP) Inspection

We are proud to announce the successful completion of our Good Laboratory Practice (GLP) inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The inspection, which took place from 15-16 October 2025 confirmed our continued compliance with GLP principles and recognised the robustness of Test Labs’ quality systems, study conduct, and data integrity. 

This positive outcome reflects the dedication, expertise, and collaborative spirit of our entire team, whose commitment to excellence and regulatory compliance remains at the heart of everything we do. 

What Does Upholding Scientific Integrity Mean at Test Labs?

Good Laboratory Practice (GLP) is an internationally recognised quality framework that ensures: 

• Consistency 
• Reliability 
• Integrity of non-clinical safety data. 

Compliance with GLP is essential for organisations involved in the generation of data used to support regulatory submissions and approvals for pharmaceuticals, chemicals, medical devices and other regulated products. 

At Test Labs, GLP principles guide our daily operations. From study design to data reporting, every step of our work is built upon a foundation of traceability, accountability, and scientific integrity. Maintaining MHRA-recognised GLP compliance demonstrates our unwavering commitment to producing high-quality, reliable results that contribute to the safe and effective development of new therapies and technologies. 

How Was the MHRA GLP Inspection Conducted?

The MHRA GLP inspection was conducted over two days and included a thorough review of: 

• Facilities. 
• Quality systems. 
• Equipment. 
• Data management. 
• Study records.  

The Inspector evaluated our compliance with the OECD Principles of Good Laboratory Practice and assessed our processes for ensuring data reliability and traceability. 

Throughout the inspection, our team demonstrated detailed knowledge of GLP requirements and showcased our comprehensive approach to quality assurance, staff training, and documentation. The inspection concluded with no critical or major findings, underscoring the strength of our GLP framework and the high standards maintained across our operations. 

How Test Labs Commits to Continuous Improvement

While we celebrate this successful inspection, GLP compliance is not a one-time achievement.  At Test Labs, we view regulatory inspections as valuable opportunities to evaluate and enhance our systems, ensuring that our practices remain aligned with evolving industry standards and regulatory expectations.
Our ongoing investment in quality and compliance includes: 

• Continuous training and development: Regular GLP and data integrity training programs ensure our staff remain fully up to date with regulatory requirements and best practices. 
• Digital transformation: We are enhancing our laboratory and data management systems to strengthen data traceability, security, and accessibility. 
• Process optimisation: Regular internal audits and performance reviews drive continuous improvement and operational efficiency. 
• Quality culture: We encourage proactive engagement, open communication, and accountability across all levels of the organisation, ensuring that quality remains everyone’s responsibility. 

This culture of continuous improvement not only sustains compliance but also fosters innovation and scientific excellence.

Why GLP Compliance Matters for Clients and Regulators

For our clients, GLP compliance provides assurance that the studies conducted at Test Labs meet the highest international standards for reliability and reproducibility. Regulatory authorities rely on GLP-compliant data to make critical decisions about the safety and efficacy of products entering the market. 

By maintaining MHRA recognition for GLP compliance, Test Labs continues to provide data that regulators and our clients can trust. This achievement reinforces our role as a dependable partner in the global life sciences ecosystem and supports our mission to advance safe and effective solutions that improve human and environmental health.

Looking Ahead: Maintaining and Exceeding GLP Standards

As research and regulatory expectations continue to change, we remain committed to maintaining and exceeding GLP standards. Our focus for the coming year includes expanding our laboratory capabilities and continuing to build on our culture of quality and transparency. 

We look forward to continuing to deliver reliable, compliant, and impactful science. We remain committed to supporting our clients and contributing to advances that make a difference in global health and safety.